Forte Capital LLC ADV Purchases 570 Shares of Core Laboratories (CLB)
Forte Capital LLC ADV increased its stake in Core Laboratories (NYSE:CLB) by 4.6% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 12,886 shares of the oil and gas company’s stock after purchasing an additional 570 shares during the quarter. Forte Capital LLC ADV’s holdings in Core Laboratories were worth $1,411,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently bought and sold shares of CLB. The Manufacturers Life Insurance Company lifted its holdings in Core Laboratories by 63.7% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,128 shares of the oil and gas company’s stock worth $114,000 after purchasing an additional 439 shares during the last quarter. Advisory Services Network LLC lifted its holdings in Core Laboratories by 33.3% in the 2nd quarter. Advisory Services Network LLC now owns 1,365 shares of the oil and gas company’s stock worth $138,000 after purchasing an additional 341 shares during the last quarter. Toronto Dominion Bank lifted its holdings in Core Laboratories by 243.6% in the 3rd quarter. Toronto Dominion Bank now owns 1,866 shares of the oil and gas company’s stock worth $184,000 after purchasing an additional 1,323 shares during the last quarter. Arrowstreet Capital Limited Partnership acquired a new stake in Core Laboratories in the 2nd quarter worth approximately $203,000. Finally, Park National Corp OH acquired a new stake in Core Laboratories in the 3rd quarter worth approximately $209,000.
Shares of Core Laboratories (CLB) traded up $0.70 during midday trading on Monday, hitting $116.00. The company had a trading volume of 318,400 shares, compared to its average volume of 416,123. The company has a quick ratio of 1.81, a current ratio of 2.18 and a debt-to-equity ratio of 1.53. The firm has a market capitalization of $5,170.00, a price-to-earnings ratio of 67.05 and a beta of 1.56. Core Laboratories has a twelve month low of $86.55 and a twelve month high of $124.99.
A number of research analysts have recently commented on the company. Deutsche Bank lowered Core Laboratories from a “buy” rating to a “hold” rating and cut their price target for the stock from $116.30 to $109.00 in a report on Thursday, January 11th. Zacks Investment Research lowered Core Laboratories from a “hold” rating to a “sell” rating in a report on Tuesday, September 26th. Scotiabank set a $136.00 price target on Core Laboratories and gave the stock a “hold” rating in a report on Wednesday, October 25th. Royal Bank of Canada reiterated a “buy” rating on shares of Core Laboratories in a report on Wednesday, October 18th. Finally, ABN Amro upgraded Core Laboratories from a “hold” rating to a “buy” rating in a report on Wednesday, October 25th. Three investment analysts have rated the stock with a sell rating, eight have given a hold rating and four have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $110.20.
WARNING: “Forte Capital LLC ADV Purchases 570 Shares of Core Laboratories (CLB)” was first posted by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this piece can be read at https://theolympiareport.com/2018/01/22/forte-capital-llc-adv-purchases-570-shares-of-core-laboratories-clb.html.
Core Laboratories Profile
Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.